Preparation of Giant Vesicles Exhibiting Visible-light-induced Morphological Changes

Published: July 21, 2016

Masanari Hirahara, Akira Tsukamoto, Hiroki Goto, Shigeru Tada, Masayuki Yagi, Yasushi Umemura

¹Department of Applied Chemistry, School of Applied Science,National Defense Academy of Japan, ²Department of Applied Physics, School of Applied Science,National Defense Academy of Japan, ³Department of Materials Science and Technology, Faculty of Engineering,Niigata University

Summary

The synthesis of ruthenium complex surfactants exhibiting photoisomerization in giant vesicles is described. The preparation and light irradiation of the giant vesicles are also described.

Abstract

We describe the preparation of giant vesicles that incorporate a photoresponsive ruthenium complex having two alkyl chains. The vesicles exhibited morphological changes when exposed to visible light. The ruthenium complex proximal-[Ru(L1)(L2)OH₂](NO₃)₂, proximal–2 (L1 is 4′-decyloxy-2,2′;6′,2″-terpyridine, L2 is 2-(2′-(6′-decyloxy)-pyridyl)quinoline) was prepared by a thermal reaction of Ru(L1)Cl₃ and L2, followed by removal of a chloride ligand. In an aqueous solution and vesicle dispersions, proximal–2 was reversibly photoisomerized to the distal isomer. Giant vesicles containing proximal–2 were prepared by hydration of phospholipid films containing proximal–2 in the dark at 80 °C. Giant vesicles were frequently found in the dispersions prepared from DOPC/proximal–2 rather than from DPPC/proximal–2 (DOPC is 1,2-dioleoyl-sn-glycero-3-phosphocholine, DPPC is 1,2-dipalmitoyl –sn-glycero-3-phosphocholine). The ratio of proximal–2 and DOPC in the vesicle preparation was varied from 5:100 to 20:100. The light-induced morphological changes were observed for proximal–2/DOPC in the presence of Na₂SO₄. However, they were highly suppressed in the presence of NaOH. Incubation of light-exposed vesicles at 45 °C in the dark induced reverse morphological changes. Morphological changes were observed under fluorescence microscopy using 635 nm (red) light. Rhodamine-DOPC [rhodamine-DOPC: 1,2-dioleoyl-sn-glycero-3-phos-phoethanolamine-N-(lissamine rhodamine B sulfonyl)] was used to fluorescently label the vesicles.

Introduction

Controlling the morphologies and shapes of macro- and meso-scale molecular assemblies by external stimuli has attracted considerable attention.¹^,² In particular, the control of vesicle morphologies by remote stimuli such as light has potential applications for drug delivery.³ In this context, organic photochromic molecules with hydrophobic and hydrophilic moieties have been widely incorporated into liposomes and polymer vesicles.⁴^,⁵^,⁶^,⁷^,⁸ However, most of the assemblies require ultraviolet (UV) light to drive the morphological changes, and their applications are limited because UV light is strongly scattered in living tissues and induces DNA damage and cell death.

Alternatively, utilization of visible or near-infrared light in the phototherapeutic window (600-1000 nm) is more favorable because of abundant sunlight and its high transmission in tissues of living organisms. In this regard, ruthenium complexes with polypyridyl ligands are suitable visible-light-responsive surfactants. They exhibit a strong visible light absorption band (ε~10⁴ M^-1 cm^-1) that induces ligand substitution⁹^,¹⁰ and photoisomerization.¹¹^,¹²^,¹³^,¹⁴^,¹⁵^,¹⁶ Incorporation of the ruthenium complexes into vesicles will expand their applications because these complexes are also known as water oxidation catalysts¹⁷^,¹⁸^,¹⁹ and bioactive molecules.²⁰^,²¹ Recently, ruthenium complexes have been incorporated into vesicles.²²^,²³^,²⁴ However, controlling morphologies of vesicles via visible-light absorption has remained challenging.

We have previously reported irreversible and reversible photoisomerization of mononuclear ruthenium aqua complexes having asymmetric bidentate ligands.²⁵^,²⁶^,²⁷^,²⁸ Recently, we synthesized novel surfactants (proximal–2, see Figure 1) that exhibit visible-light photoisomerization equilibria with distal–2 by introducing an alkyl chain on each tridentate and bidentate ligand of the ruthenium aqua complex. Giant vesicles incorporating proximal–2 undergo morphological changes under the irradiation of visible light in the phototherapeutic window.²⁹ Herein, we describe the detailed syntheses of ruthenium complexes and the preparation of giant vesicles. The protocols will enable researchers to prepare, characterize, and utilize light-responsive giant vesicles.

Figure 1: Ruthenium complex surfactants. Reversible photoisomerization equilibrium between proximal- and distal- type complex of 1 (top) and 2 (bottom). Please click here to view a larger version of this figure.

Protocol

NOTE: Ru(tpy)Cl₃³⁰, L1²⁹, 2-(2'-(6'-chloro)-pyridyl)quinoline²⁹, proximal– 1²⁹ were synthesized as previously described.

1. Synthesis of 2-(2'-(6'-decyloxy)-pyridyl)quinoline (L2)

Add 2-(2'-(6'-chloro)-pyridyl)quinoline (16.3 mg, 63 µmol), 1-decanol (0.1 mL), dimethyl sulfoxide (1 mL), KOH (0.12 g) to a 50 mL round bottom flask equipped with a stir bar.
Heat and stir the reaction mixture in an 80 °C oil bath for 4 h.
Transfer the reaction mixture to a separating funnel, and add chloroform (ca. 20 mL) and water (ca. 20 mL). Shake the funnel for 2-3 minutes and wait several hours for complete separation into two layers. Collect the bottom organic layer, add anhydrous magnesium sulfate to absorb the water in the chloroform, filter with folded filtration paper, and remove the solvent in a rotary evaporator at 40 °C to obtain the oily crude product.
Purify the product with silica gel chromatography (1.5 cm×20 cm) using a mixed solvent (AcOEt/hexane/CHCl₃, 1:5:5, v/v/v) as an eluent.²⁹ The product band emits blue light in the silica gel under UV light (254 nm).
Collect the fractions of the blue band eluted from the column to the glass vials, and remove the solvent in a rotary evaporator at 40 °C. Check the product purity with ¹H and ¹³C NMR in CDCl₃ referenced with tetramethylsilane (TMS). The oily product contains a small amount of 1-decanol as impurity.²⁹

2. Synthesis of proximal -2

Synthesis of [Ru(L1)Cl ₃ ]
1. Add RuCl₃·3H₂O (60 mg, 0.23 mmol), L1 (80 mg, 0.21 mmol), and ethanol (EtOH, 40 mL) to a 50 mL round bottom flask equipped with a stir bar.
2. Reflux and stir the reaction mixture in an oil bath for 4 h.
3. Collect the yellow-brown precipitate with vacuum filtration, and wash with water (ca. 5 mL).
4. Dry the product in vacuum for a yield of approximately 98 mg (80% yield).
Synthesis of [Ru(L1)(L2)Cl]Cl
1. Add [Ru(L1)Cl₃] (47.2 mg, 0.078 mmol), triethylamine (0.2 mL), EtOH (12mL), water (4mL), LiCl (50 mg), and purified product of L2 synthesized from 0.10 mmol of 2-(2'-(6'-chloro)-pyridyl)quinoline to a 50 mL round bottom flask equipped with a stir bar.
2. Reflux the reaction mixture in an oil bath for 4 h.
3. Filter the purple solution with diatomite (ca. 2 g) on the filter paper in a glass funnel to remove unreacted [Ru(L1)Cl₃].
4. Reduce the solvent to ca. 3 mL in a rotary evaporator at 45 °C, collect the purple precipitate by vacuum filtration, and wash with diethyl ether.
5. Purify the crude solid (44.2 mg) with size exclusion chromatography on a dextran gel, using methanol as eluent (column length: 20 cm).²⁹ Collect fractions of the second purple band eluted from the column to glass vials. Spot the eluted fractions on the thin layer chromatography plate (ca. 1 µL for each spot). Check the purity using a mixed eluent (MeOH/saturated aqueous solution of NaCl, 30:1, v/v). Repeat the purification process two or three times.
6. Remove the solvent on a rotary evaporator at 45 °C and dry in vacuum to obtain 30.1 mg of the product (39% yield). Check the purity with by ¹H and ¹³C NMR in CDCl₃ referenced with TMS.²⁹
Synthesis of proximal- [Ru(L1)(L2)OH ₂ ](NO ₃ ) ₂ ( proximal- 2)
1. Add proximal-[Ru(L1)(L2)Cl]Cl (16.3 mg, 0.017 mmol), water (3 mL), acetone (10 mL), and an aqueous solution of 0.1 M AgNO₃ (0.60 mL, 0.060 mmol) to a 50 mL round bottom flask equipped with a stir bar. Cover the flask with aluminum foil
2. Reflux the reaction mixture in an oil bath for 2 h in the dark.
3. Filter the purple solution with diatomite (ca. 2 g) on the filter paper in a glass funnel.
4. Reduce the solvent to ca. 3 mL in a rotary evaporator at 45 °C, collect the purple solid, and wash it with water.
5. Dry in vacuum to obtain 12.6 mg of the product (75% yield). Check the purity with ¹H and ¹³C NMR in the mix solvent of d-acetone and D₂O (1:1, v/v) referenced with TMS.²⁹

3. Standard conditions for preparation of vesicles

To prepare 0.5 mM stock solution A, dissolve 4.0 mg of proximal– 2 in 8.0 mL of chloroform. Store the stock solution in the dark and refrigerate.
To prepare 1.0 mM stock solution B, dissolve 15.7 mg of DOPC in 20.0 mL of chloroform.
To prepare 0.1 mM stock solution C, dilute 1 mg/mL solution of rhodamine-DOPC with 6.6 mL of chloroform.
Mix 40 µL of stock solution A and 100 µL of stock solution B in an amber glass vial. For the fluorescence microscopy experiments, add 100 µL of stock solution C.
Seal the vial with a rubber septum equipped with a nitrogen inlet and outlet, and dry the solution under nitrogen flow overnight.
Remove the septum and heat the vial in an 80 °C oven for 30 min.
Add 0.1 mL of pure water to the vial. Seal and incubate the vial at 80 °C overnight. The lipid film is gradually hydrated to yield a reddish-purple vesicle dispersion that settles to the bottom of the vial.
Store the vial in a refrigerator in the dark. The vesicle dispersion should be used within a week.

4. Preparation of Plates

Rinse glass plates with ethanol and acetone, sonicate in ethanol for 5 min, and dry at 50 °C for 20-30 min.
Cut a silicon film (thickness = 0.2 mm) into a 20 mm×20 mm square with a knife.
Make a 5 mm hole with a hole punch at the center of the film, and remove plastic covers.
Wet one side of the silicon film with diluted detergent (0.3 %) and then wipe it with cleaning tissue.
Attach the edge of the film to a glass plate, and slowly lay the film in order to extrude the bubbles.
Slowly shake the amber vial containing the vesicles, and with a micropipette transfer a small drop (diameter ~1 mm) to the center of the hole on the glass plate.
Place a cover glass (18 mm × 18 mm) on the vesicle dispersion.

5. Morphological changes of giant vesicles under visible light irradiation

Perform experiments in the dark at a constant temperature of 25 °C.
Put the glass plate with sample droplets under a digital microscope (700X), and acquire images.
Expose the sample plate with emission from a halogen lamp (distance from the plate: 2.5 cm) at a constant intensity of 120 mWcm^-2.

6. Morphological changes of giant vesicles under red light irradiation

Perform experiments in the dark at a constant temperature of 25 °C.
Put the glass plate with sample droplets containing DOPC, proximal–2, and rhodamine-DOPC under a confocal microscope.
Acquire images with a confocal microscope. Transmit excitation light (559 nm) and emission light (575 nm) through the same objective.
Turn on the LED laser (635 nm), and adjust its intensity to 20 mW.

Representative Results

We obtained high-purity proximal–2 to form spherical and giant multilamellar vesicles (proximal-2/DOPC, proximal-2: DOPC=20:100) 15-µm average diameters (see Table 1).²⁹ Several layers were found inside the vesicles (Figures 2A and 2C). The inner spheres of the vesicles in Figures 2B, and 2D were darker than the outer spheres because of the concentric lipid layers. The vesicles containing proximal–2 displayed various morphological changes under the irradiation of visible light (λ > 380 nm). The vesicle diameter in Figure 2A both increased and then decreased, while that in Figures 2B was distorted and had budding. The morphological changes were not usually observed for vesicles prepared from DOPC alone. Most of the morphological changes depended on the amount of proximal–2 (Table 1). Changes were also observed for proximal–2/DPPC vesicles (DPPC=1,2-dipalmitoyl-sn-glycero-3-phosphocholine). In contrast, proximal–1/DOPC vesicles did not show visible-light-induced morphological changes.

Figure 4 shows vesicles prepared in the presence of Na₂SO₄ (Figure 4A) and NaOH (Figure 4C). The photoinduced morphological changes were frequently observed for the vesicles containing Na₂SO₄ (Figure 4B) while those were not observed for the vesicles containing NaOH (Figure 4D). Figure 5 shows photo- and thermal-induced morphological changes of vesicles of proximal–2/DOPC. The budded vesicles under light irradiation recovered the original spherical vesicle after incubation in the dark.

The morphological changes in proximal–2/DOPC/rhodamine-DOPC vesicles under red light (635 nm) irradiation are depicted in Figure 6. We observed budding of granule vesicles from the vesicle edges, which is similar to that observed when exposed to visible light (λ > 380 nm).

Entry	Change from standard conditions^a	Average size/ μm	Morphological change / %
1	none	15	79
2	proximal-1, 10 nmol	20	11
3	no proximal-2	24	8
4	proximal-2, 10 nmol	18	80
5	proximal-2, 5 nmol	22	33
6	DPPC	16	50
7	500 nmol Na₂SO₄	15	80
8	1000 nmol NaOH	21	10
9	100 nmol NaOH	27	27
^aIn standard conditions, vesicles are prepared from DOPC (100 nmol), proximal-2 (20 nmol, 20 mol%), and water (100 μL).

Table 1: Dependence of morphological changes on vesicle preparation parameters. The percentages of vesicles showing morphological changes were calculated from vesicles (>10 mm) under visible light irradiation (λ > 380 nm, 120 mWcm⁻²) for 30 min.

Figure 2: Microscope images of vesicles under irradiation with a 100 W halogen lamp (λ>380 nm, 120 mWcm^-2). A) and B): proximal–2/DOPC (DOPC: 100 nmol, proximal–2: 20 nmol (20 mol%), water 0.1 mL). C) Vesicles prepared from DOPC alone (DOPC: 100 nmol, water 0.1 mL). D): proximal–2/DPPC (DPPC: 100 nmol, proximal–2: 20 nmol (20 mol%), water 0.1 mL). Parts reproduced from ref²⁹ with permission of John Wiley and Sons, Inc. Please click here to view a larger version of this figure.

Figure 3: Microscope images of vesicles before light exposure. A), proximal–2/DPPC (DPPC: 100 nmol, proximal–2: 20 nmol (20 mol%), water 0.1 mL). B), proximal–2/DOPC (DOPC: 100 nmol, proximal–2: 20 nmol (20 mol%), water 0.1 mL). Please click here to view a larger version of this figure.

Figure 4: Microscope images of vesicles under the irradiation with a 100 W halogen lamp (λ>380 nm, 120 mWcm^-2) in the presence of ionic compounds. A) and B), proximal–2/DOPC (DOPC: 100 nmol, proximal–2: 20 nmol (20 mol%), NaOH: 1000 nmol, water 0.1 mL). C) and D), proximal–2/DOPC (DOPC: 100 nmol, proximal–2: 20 nmol (20 mol%), Na₂SO₄: 500 nmol, water 0.1 mL). Left panels: before light irradiation and right panels: after light irradiation for 27 min with a 100 W halogen lamp. Please click here to view a larger version of this figure.

Figure 5: Photo- and thermal-induced morphological changes. proximal–2/DOPC (DOPC: 100 nmol, proximal–2: 20 nmol (20 mol%), water 0.1 mL). The vesicle dispersions were irradiated under visible light at 25 °C (top) and then incubated in the dark at 45 °C (bottom). Scale bar: 50 µm. Please click here to view a larger version of this figure.

Figure 6: Morphological changes of giant vesicles exposed to 635-nm light. Confocal fluorescence microscope (A and C), and digital microscope (B and D) images of giant vesicles containing DOPC (100 nmol), proximal–2 (20 nmol), and rhodamine-DOPC (10 nmol) under irradiation with a diode laser (635 nm, 20 mW). The fluorescence microscopy was acquired with excitation at 559 nm excitation. Scale bar: 30 µm. Reproduced from ref²⁹with permission of John Wiley and Sons, Inc.

Discussion

The ruthenium chloro complex proximal-[Ru(L1)(L2)Cl]⁺ was prepared by thermal synthesis of Ru(L1)Cl₃ and a bidentate ligand L2 in the presence of triethylamine. The proximal isomer was the major product and a distal isomer and Ru(L1)₂²⁺ was a minor impurity. The crude product was purified with size-exclusion chromatography using methanol as an eluent. Coordinating solvents, such as water and acetonitrile, should not be used. Slow dropping of the eluent (3-4 drops per minute) is required to separate the product from impurities. The product purification can be performed under room light because proximal-[Ru(L1)(L2)Cl]⁺ does not photoisomerize in methanol. The aquation of proximal-[Ru(L1)(L2)Cl]⁺ to proximal-[Ru(L1)(L2)OH₂]²⁺ (proximal–2) should be performed in the dark to prevent photoisomerization of the product.

Giant vesicles were prepared by simple hydration of lipid films containing the phospholipids and proximal–2. The DOPC and proximal–2 vesicles were spherical and multilamellar, while those obtained from DPPC and proximal–2 were slightly distorted as depicted in Figure 2. More giant vesicles were formed from proximal–2/DOPC than from proximal–2/DPPC, as depicted in Figure 3. The hydration temperature of the films should be more than 50 °C; giant vesicles were not formed after room-temperature hydration. The hydration time was varied over 5-24 hours with no significant differences in vesicle morphologies. After film hydration, the vesicle-containing samples were stored in the dark at 4 °C and used within a week. The vesicles can be prepared in the presence of ionic compounds such as Na₂SO₄ and NaOH, as depicted in Table 1. As shown in Figures 4C and 4D, the morphological changes were highly suppressed in the presence of NaOH (Figure 4C and 4D). The results arise from the formation of ruthenium-hydroxo complex (Ru-OH), which has been reported as inactive for photoisomerization.²⁸

We previously reported that the mixture of proximal- and distal-2 in the photostationary state displayed thermal back isomerization to the proximal isomer in an aqueous solution at 45 °C. In the vesicle dispersions, vesicles were irradiated under the visible light at 25 °C, and then incubated in the dark at 45 °C as depicted in Figure 5. The vesicles displayed budding from the edge under the light irradiation due to the photoisomerization to distal–2. The budded vesicles were recovered to the original spherical vesicles after incubating the vesicle in the dark at 45 °C for 30 min. The back morphological change may arise from the thermal back isomerization of distal–2 to proximal–2.

Fluorescence microscopy was used to examine the fluorescent surfactants rhodamine-DOPC and fluorescein-DOPC [fluorescein-DOPC is 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) ammonium salt]. No fluorescence was observed for proximal–2/DOPC/fluorescein-DOPC vesicles because of the overlapping emission band of the fluorescein dye with a metal-to-ligand charge-transfer absorption band of proximal–2. In contrast, rhodamine-DOPC can be used in fluorescence experiments because of its red emission (575 nm). The percentage of the rhodamine-DOPC (20 mol %DOPC) was higher than previous studies⁶ because the absorption of rhodamine-DOPC overlapped with that of proximal–2.

Common troubleshooting tips for the protocols are: (a) clean the amber vials before the preparation; (b) gently evaporate the chloroform from the lipids and the ruthenium complex under nitrogen gas flow; and (c) protect the samples from light before the measurements.

Generally, giant vesicles have been prepared from simple hydration, electroformation, or centrifugation methods.³¹ Electroformation methods have been widely used for the preparation of giant unilamellar vesicles. However, we did not adopt the method in order to avoid redox reactions of the ruthenium complex under the electric field. In this protocol, we prepared giant multilamellar vesicles by hydration of lipid films with distilled water or aqueous solutions containing 10^-4 M ionic compounds. It should be noted that it is difficult to prepare giant vesicles of proximal–2/DOPC in a highly concentrated aqueous solution of ionic compounds (> 10^-2M). The red light responsive vesicles of proximal-2/DOPC are contrastive to the UV-light responsive vesicles reported so far.⁶^,⁷^,⁸ We are now trying to prepare the giant vesicles containing the ruthenium complex under physiological conditions.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors have no acknowledgements.

Materials

Triethylamine	Wako Pure Chemical Industries, Ltd.	202-02646
Lithium Chloride	Wako Pure Chemical Industries, Ltd.	125-01161
Chloroform	Kanto Chemical Co. Ltd.	07278-03	Used for vesicle preparation
Chloroform	Junsei Chemical Co. Ltd.	28560-0382	Used for ligand synthesis
Acetone	Junsei Chemical Co. Ltd.	11265-0382
Ethanol	Junsei Chemical Co. Ltd.	17065-0382
Ethyl Acetate	Junsei Chemical Co. Ltd.	67150-0382
Hexane	Junsei Chemical Co. Ltd.	31055-0382
Silica gel	Kanto Chemical Co. Ltd.	37558-79	100-210 μm
1-decanol	Tokyo Chemical Industry Co., Ltd.	D0031	25 mL
Potassium hydroxide	Kanto Chemical Co. Ltd.	32344-00
Sodium hydrixude	Wako Pure Chemical Industries, Ltd.	197-02125
Dimethyl sulfoxide (DMSO)	Kanto Chemical Co. Ltd.	10378-00
d-DMSO	Sigma-Aldrich	166290100
CD₃OD	Kanto Chemical Co. Ltd.	25221-43
d-Acetone	Kanto Chemical Co. Ltd.	01054-43
D₂O	Cambridge Isotope Laboratories, Inc.	DLM-4-100
Ruthenium chloride n-Hydrate	Wako Pure Chemical Industries, Ltd.	183-00823
2,2':6',2"-Terpyridine	Sigma-Aldrich	234672-5G
0.1 mol/L Silver nitrate solution	Wako Pure Chemical Industries, Ltd.	192-00855
Sodium sulfate	Kanto Chemical Co. Ltd.	37280-00
1,2 Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)	Wako Pure Chemical Industries, Ltd.	160-12781	100 mg, stored at -20°C
1,2 Dioleoyl-sn-glycero-3-phosphocholine (DOPC)	Sigma-Aldrich	P6354-100mg	100 mg, stored at -20°C
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (ammonium salt)	Avanti Polar Lipids, Inc.	Avanti 810332p	5 mg, stored at -20°C
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)	Avanti Polar Lipids, Inc.	Avanti 810150c	1 mg, stored at -20°C
Dextran gel	GE healthcare Japan	17009010	Sephadex LH-20
Amber glass vial	Maruemu	0407-06
Septum	Sigma-Aldrich	Z564648-100EA
Heater	Advantech	DRM 320 DB
Silicon film	AS ONE	6-9085-03	Thickness: 0.2 mm
Slide glass	Matsunami	S003130	76×26 mm, thickness: 0.8-1.0 mm
Cover glass	Matsunami	C218181	18×18 mm, thickness: 0.12-0.17 mm
Transfer pipette	Brand GMBH	704774
Round-bottom flask	Vidtech	1500-05
Sonicator	AS ONE	1-4591-32
Optical power meter	OPHIR	ORION/PD P/N 1Z01803
Oil bath	Riko	MH-3D
Magnetic stirrer	Riko	MSR-10
Diatomite	Wako Pure Chemical Industries, Ltd.	537-02305	Celite 545
Evaporator	Yamato	RE-52
Glass funnel	Kiriyama	SB-21	10 mL, 21 mmφ
Bell jar	Kiriyama	VKB-200
Filter paper	Kiriyama	No.4	21 mmφ
Optical microscope	KEYENCE	VHX-5000
Confocal fluorescence microscope	Olympus	FV-1000

References

Natansohn, A., Rochon, P. Photoinduced Motions in Azo-Containing Polymers. Chem. Rev. 102 (11), 4139-4176 (2002).
Ichimura, K., Oh, S. -. K., Nakagawa, M. Light-Driven Motion of Liquids on a Photoresponsive Surface. Science. 288 (5471), 1624-1626 (2000).
Shum, P., Kim, J. -. M., Thompson, D. H. Phototriggering of liposomal drug delivery systems. Adv. Drug Deliv. Rev. 53 (3), 273-284 (2001).
Mabrouk, E., Cuvelier, D., Brochard-Wyart, F., Nassoy, P., Li, M. -. H. Bursting of sensitive polymersomes induced by curling. Proc. Natl. Acad. Sci. U. S. A. 106 (18), 7294-7298 (2009).
Hamada, T., Sato, Y. T., Yoshikawa, K., Nagasaki, T. Reversible Photoswitching in a Cell-Sized Vesicle. Langmuir. 21 (17), 7626-7628 (2005).
Diguet, A., et al. UV-Induced Bursting of Cell-Sized Multicomponent Lipid Vesicles in a Photosensitive Surfactant Solution. J. Am. Chem. Soc. 134 (10), 4898-4904 (2012).
Hamada, T., Sugimoto, R., Vestergaard, M. d. C., Nagasaki, T., Takagi, M. Membrane Disk and Sphere: Controllable Mesoscopic Structures for the Capture and Release of a Targeted Object. J. Am. Chem. Soc. 132 (30), 10528-10532 (2010).
Li, L., et al. Light-Switchable Vesicles from Liquid-Crystalline Homopolymer-Surfactant Complexes. Angew. Chem. Int. Ed. 51 (46), 11616-11619 (2012).
Pinnick, D. V., Durham, B. Photosubstitution reactions of Ru(bpy)2XYn+ complexes. Inorg. Chem. 23 (10), 1440-1445 (1984).
Rack, J. J., Winkler, J. R., Gray, H. B. Phototriggered Ru(II)−Dimethylsulfoxide Linkage Isomerization in Crystals and Films. J. Am. Chem. Soc. 123 (10), 2432-2433 (2001).
Durham, B., Walsh, J. L., Carter, C. L., Meyer, T. J. Synthetic Applications of Photosubstitution Reactions of Poly(Pyridyl) Complexes of Ruthenium(II). Inorg. Chem. 19 (4), 860-865 (1980).
Bonnet, S., Collin, J. -. P., Sauvage, J. -. P. Light-Induced Geometrical Changes in Acyclic Ruthenium(II) Complexes and Their Ruthena−Macrocyclic Analogues. Inorg. Chem. 46 (25), 10520-10533 (2007).
Bonnet, S., Collin, J. -. P., Sauvage, J. -. P. Synthesis and Photochemistry of a Two-Position Ru(terpy)(phen)(L)2+ Scorpionate Complex. Inorg. Chem. 45 (10), 4024-4034 (2006).
Miyazaki, S., Kojima, T., Fukuzumi, S. Photochemical and Thermal Isomerization of a Ruthenium(II)−Alloxazine Complex Involving an Unusual Coordination Mode. J. Am. Chem. Soc. 130 (5), 1556-1557 (2008).
Padhi, S. K., Fukuda, R., Ehara, M., Tanaka, K. Photoisomerization and Proton-Coupled Electron Transfer (PCET) Promoted Water Oxidation by Mononuclear Cyclometalated Ruthenium Catalysts. Inorg. Chem. 51 (9), 5386-5392 (2012).
King, A. W., Wang, L., Rack, J. J. Excited State Dynamics and Isomerization in Ruthenium Sulfoxide Complexes. Acc. Chem. Res. 48 (4), 1115-1122 (2015).
Concepcion, J. J., Jurss, J. W., Templeton, J. L., Meyer, T. J. One Site is Enough. Catalytic Water Oxidation by [Ru(tpy)(bpm)(OH2)]2+ and [Ru(tpy)(bpz)(OH2)]2+. J. Am. Chem. Soc. 130 (49), 16462-16463 (2008).
Duan, L., et al. A molecular ruthenium catalyst with water-oxidation activity comparable to that of photosystem II. Nat. Chem. 4 (5), 418-423 (2012).
Boyer, J. L., et al. Effects of a Proximal Base on Water Oxidation and Proton Reduction Catalyzed by Geometric Isomers of [Ru(tpy)(pynap)(OH2)]2+. Angew. Chem. Int. Ed. 50 (52), 12600-12604 (2011).
Howerton, B. S., Heidary, D. K., Glazer, E. C. Strained Ruthenium Complexes Are Potent Light-Activated Anticancer Agents. J. Am. Chem. Soc. 134 (20), 8324-8327 (2012).
Albani, B. A., et al. Marked Improvement in Photoinduced Cell Death by a New Tris-heteroleptic Complex with Dual Action: Singlet Oxygen Sensitization and Ligand Dissociation. J. Am. Chem. Soc. 136 (49), 17095-17101 (2014).
Bonnet, S., Limburg, B., Meeldijk, J. D., Gebbink, R. J. M. K., Killian, J. A. Ruthenium-Decorated Lipid Vesicles: Light-Induced Release of [Ru(terpy)(bpy)(OH2)]2+ and Thermal Back Coordination. J. Am. Chem. Soc. 133 (2), 252-261 (2011).
Askes, S. H. C., Bahreman, A., Bonnet, S. Activation of a Photodissociative Ruthenium Complex by Triplet-Triplet Annihilation Upconversion in Liposomes. Angew. Chem. Int. Ed. 53 (4), 1029-1033 (2014).
Koshiyama, T., et al. Regulation of a cerium(iv)-driven O2 evolution reaction using composites of liposome and lipophilic ruthenium complexes. Dalton Trans. 44 (34), 15126-15129 (2015).
Yamazaki, H., Hakamata, T., Komi, M., Yagi, M. Stoichiometric Photoisomerization of Mononuclear Ruthenium(II) Monoaquo Complexes Controlling Redox Properties and Water Oxidation Catalysis. J. Am. Chem. Soc. 133 (23), 8846-8849 (2011).
Hirahara, M., et al. Mechanisms of Photoisomerization and Water-Oxidation Catalysis of Mononuclear Ruthenium(II) Monoaquo Complexes. Inorg. Chem. 52 (11), 6354-6364 (2013).
Hirahara, M., et al. New Series of Dinuclear Ruthenium(II) Complexes Synthesized Using Photoisomerization for Efficient Water Oxidation Catalysis. Inorg. Chem. 54 (15), 7627-7635 (2015).
Hirahara, M., et al. Mechanisms and factors controlling photoisomerization equilibrium, ligand exchange and water oxidation catalysis of mononuclear ruthenium(II) complexes. Eur. J. Inorg. Chem. 2015, 3892-3903 (2015).
Hirahara, M., et al. Visible-Light-Induced Morphological Changes of Giant Vesicles by Photoisomerization of a Ruthenium Aqua Complex. Chem. Eur. J. 22 (8), 2590-2594 (2016).
Sullivan, B. P., Calvert, J. M., Meyer, T. J. Cis-trans isomerism in (trpy)(PPh3)RuC12. Comparisons between the chemical and physical properties of a cis-trans isomeric pair. Inorg. Chem. 19 (5), 1404-1407 (1980).
Walde, P., Cosentino, K., Engel, H., Stano, P. Giant Vesicles: Preparations and Applications. ChemBioChem. 11 (7), 848-865 (2010).